Concepedia

Anjana Patel Lewis

AP

Statistics

Publications

3

Citations

175

H-Index

3

Active since

2016

Affiliations

Eli Lilly (United States)(Current)

Jubilant Life Sciences (India)

Anjana Patel Lewis is an author at Eli Lilly (United States) specializing in receptor pharmacology, pharmacology, and ligand binding.

Publications per year

2016–2018

3

Publications

3

Structural basis for GPR40 allosteric agonism and incretin stimulation

Joseph D. Ho, Betty Chau, Logan Rodgers et al. · Nature Communications · 2018 · 85 citations · Full text

, , +17

The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)

Chafiq Hamdouchi, Steven D. Kahl, Anjana Patel Lewis et al. · Journal of Medicinal Chemistry · 2016 · 60 citations · Full text

, , +17

Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus

Chafiq Hamdouchi, Pranab Maiti, Alan M. Warshawsky et al. · Journal of Medicinal Chemistry · 2017 · 30 citations · Full text

, , +17

1–3 of 3